Canton Strategic Holdings Inc CNTN
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-01-12 |
| Shares Out. | 77,120,000 |
| Website | cantonstrategic.com ↗ |
| Phone | 13026457400 |
| Employees | 12 |
| Revenue | $1.5M |
| Gross Profit | $1.5M |
| Net Income | -$19.3M |
| Free Cash Flow | -$22.2M |
| Total Assets | $564.6M |
| Total Liabilities | $109.7M |
| Equity | $454.9M |
About Canton Strategic Holdings Inc
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
Canton Strategic Holdings Inc is a publicly traded company under the ticker symbol CNTN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2025-12-01)